Getting you a comprehensive review of the product
Reading every ingredient in the formula…
Reading every ingredient in the formula…
Join The Clean Sheet™ community
Science-backed beauty tips, ingredient alerts, and early access. Straight to your WhatsApp.
Join for free →
This serum offers a robust blend of anti-dandruff actives in a well-designed formula, but its ambitious claims of 'treating' dandruff and quantified results would benefit from more transparent and detailed clinical study disclosures to fully meet regulatory standards.
₹474 • Analysed 8 September 2026
This Minimalist Anti-Dandruff Serum is priced at ₹474 for 30ml, positioning it as a mid-range to premium scalp treatment in the Indian market. Its water-based, non-greasy formula is well-suited for India's often humid climate, preventing a heavy feel. The brand's claim 'treats dandruff & itching' and quantified results ('45% reduction in Dandruff in 4 weeks') are ambitious and trigger ASCI scrutiny for absolute language and lack of full study disclosure, and also border on CDSCO drug claims for treating a medical condition without a drug license.
Independent and free. The Clean Sheet takes no money from brands to review, rank, or approve a product. This is a web evidence review, not a Clean Sheet certification. We checked the ingredient list, publicly available test reports, marketing claims, and formula logic using only public information available at the time of review.
Oligopeptide-29 concentration of 0.8% is stated in the product name. Other actives (Climbazole, Piroctone Olamine, Hexamidine Diisethionate) are present in the INCI.
Brand states 'We have evaluated the efficacy through a consumer study' with quantified results: '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'. However, it also notes '_Based on studies conducted by suppliers & independent researchers. Actual results may vary._'
Supported by consumer study results showing '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'.
General ingredient research for Panthenol, Glycerin, and the overall anti-dandruff action supports a healthier scalp environment.
Oligopeptide-29 0.8% is disclosed. Other key actives (Salicylic Acid, Piroctone Olamine, Climbazole, Hexamidine Diisethionate, Propanediol Caprylate, Capryloyl Glycine) are listed high in the INCI, before Phenoxyethanol, indicating concentrations likely above 1%.
The INCI starts with Propylene Glycol, Glycerin, PEG-12 Dimethicone, indicating a lightweight, water-soluble base.
The product contains multiple ingredients (Climbazole, Piroctone Olamine, Hexamidine Diisethionate, Oligopeptide-29, Propanediol Caprylate) specifically described as targeting dandruff-causing fungi.
Capryloyl Glycine is listed in the INCI. Ingredient research supports its sebum-regulating properties.
What we could confirm from public sources and the verified ingredient list.
Ingredient Safety & Toxicity
Full ingredient list retrieved and verified against the product page (beminimalist.co).
Screened against the ingredient database (10 of 18 ingredients matched); no cosmetics-prohibited ingredient found.
No ingredient with a recognised endocrine-activity concern found in the database.
No IARC-classified or formaldehyde-releasing ingredient found in the database screen.
No commonly-comedogenic ingredient found - a reasonable fit for acne-prone skin.
Irritation & Allergen Risk
No EU-declarable or database-flagged allergen found in the list.
No high-sensitisation preservative (MI/MCI/formaldehyde-releaser) from our screen was found.
Brand states a patch test (HRIPT) was performed.
Brand claims dermatologist testing (claim stated; underlying report not seen).
Ingredient Transparency
The full INCI list is publicly available, not just hero ingredients.
Active percentages are disclosed for the hero ingredient(s).
Any proprietary 'complex' is broken down into its actual ingredients.
Ingredients are listed in the descending order required by India Cosmetics Rules 2020.
Standards & Compliance
Usage warnings and directions are clear on the label.
No retinoid or other pregnancy-cautioned active found in the screen.
Screened against a curated reference set that we are continuing to verify and expand, so “clear” means no flag from that set, not a guarantee. Not a substitute for a full toxicological or clinical assessment.
| Ingredient |
|---|
Propylene Glycol |
Glycerin |
PEG-12 Dimethicone |
Xylitylglucoside |
Salicylic Acid |
Ethyl Lauroyl Arginate HCl |
Panthenol |
Piroctone Olamine |
Climbazole |
Hexamidine Diisethionate |
Oligopeptide-29 |
Propanediol Caprylate |
Aqua |
Hexylene Glycol |
Capryloyl Glycine |
Phenoxyethanol |
Anhydroxylitol |
Xylitol |
Ethylhexylglycerin |
INCI order as declared on packaging. Position reflects approximate concentration (high to low).
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
“treats dandruff & itching”
The claim 'treats dandruff' uses therapeutic language for a medical condition. While the actives (Climbazole, Piroctone Olamine) are permitted in cosmetics, the strong claim of 'treats' could be seen as crossing into drug territory under the Drugs & Cosmetics Act 1940 if not appropriately licensed.
“45% reduction in Dandruff in 4 weeks”
This quantified claim lacks publicly available details of the consumer study (sample size, methodology, full report) to verify its basis, which is required for specific percentage claims under ASCI guidelines.
“38% reduction in Scalp irritation in 4 weeks”
This quantified claim lacks publicly available details of the consumer study (sample size, methodology, full report) to verify its basis, which is required for specific percentage claims under ASCI guidelines.
Oligopeptide-29 concentration of 0.8% is stated in the product name. Other actives (Climbazole, Piroctone Olamine, Hexamidine Diisethionate) are present in the INCI.
Mentioned only
Brand states 'We have evaluated the efficacy through a consumer study' with quantified results: '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'. However, it also notes '_Based on studies conducted by suppliers & independent researchers. Actual results may vary._'
Evidence visible
Supported by consumer study results showing '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'.
Evidence visible
General ingredient research for Panthenol, Glycerin, and the overall anti-dandruff action supports a healthier scalp environment.
Mentioned only
Oligopeptide-29 0.8% is disclosed. Other key actives (Salicylic Acid, Piroctone Olamine, Climbazole, Hexamidine Diisethionate, Propanediol Caprylate, Capryloyl Glycine) are listed high in the INCI, before Phenoxyethanol, indicating concentrations likely above 1%.
Mentioned only
The INCI starts with Propylene Glycol, Glycerin, PEG-12 Dimethicone, indicating a lightweight, water-soluble base.
Mentioned only
The product contains multiple ingredients (Climbazole, Piroctone Olamine, Hexamidine Diisethionate, Oligopeptide-29, Propanediol Caprylate) specifically described as targeting dandruff-causing fungi.
Mentioned only
Capryloyl Glycine is listed in the INCI. Ingredient research supports its sebum-regulating properties.
Mentioned only
Salicylic Acid is listed in the INCI. Ingredient research supports its exfoliating properties.
Mentioned only
Oligopeptide-29 is listed in the INCI. Ingredient research supports its antimicrobial properties.
Mentioned only
This review evaluates brand claims against visible evidence and formula logic. It does not replace a full ingredient safety analysis or a clinical product test. Results vary by individual, and the consumer should always read the full ingredient list and follow usage guidance.
Are you the brand? If you have published test data or want to request a re-review, write to us at hello@thecleansheet.in.
Brand references ingredient origin / traceability.
No IARC-classified or formaldehyde-releasing ingredient found in the database screen.
No commonly-comedogenic ingredient found - a reasonable fit for acne-prone skin.
Irritation & Allergen Risk
No EU-declarable or database-flagged allergen found in the list.
No high-sensitisation preservative (MI/MCI/formaldehyde-releaser) from our screen was found.
Brand states a patch test (HRIPT) was performed.
Brand claims dermatologist testing (claim stated; underlying report not seen).
Ingredient Transparency
The full INCI list is publicly available, not just hero ingredients.
Active percentages are disclosed for the hero ingredient(s).
Any proprietary 'complex' is broken down into its actual ingredients.
Ingredients are listed in the descending order required by India Cosmetics Rules 2020.
Brand references ingredient origin / traceability.
Standards & Compliance
Usage warnings and directions are clear on the label.
No retinoid or other pregnancy-cautioned active found in the screen.
Screened against a curated reference set that we are continuing to verify and expand, so “clear” means no flag from that set, not a guarantee. Not a substitute for a full toxicological or clinical assessment.
Supported by consumer study results showing '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'.
General ingredient research for Panthenol, Glycerin, and the overall anti-dandruff action supports a healthier scalp environment.
Oligopeptide-29 0.8% is disclosed. Other key actives (Salicylic Acid, Piroctone Olamine, Climbazole, Hexamidine Diisethionate, Propanediol Caprylate, Capryloyl Glycine) are listed high in the INCI, before Phenoxyethanol, indicating concentrations likely above 1%.
The INCI starts with Propylene Glycol, Glycerin, PEG-12 Dimethicone, indicating a lightweight, water-soluble base.
The product contains multiple ingredients (Climbazole, Piroctone Olamine, Hexamidine Diisethionate, Oligopeptide-29, Propanediol Caprylate) specifically described as targeting dandruff-causing fungi.
Capryloyl Glycine is listed in the INCI. Ingredient research supports its sebum-regulating properties.
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
Oligopeptide-29 concentration of 0.8% is stated in the product name. Other actives (Climbazole, Piroctone Olamine, Hexamidine Diisethionate) are present in the INCI.
Mentioned only
Brand states 'We have evaluated the efficacy through a consumer study' with quantified results: '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'. However, it also notes '_Based on studies conducted by suppliers & independent researchers. Actual results may vary._'
Evidence visible
Supported by consumer study results showing '45% reduction in Dandruff in 4 weeks' and '38% reduction in Scalp irritation in 4 weeks'.
Evidence visible
General ingredient research for Panthenol, Glycerin, and the overall anti-dandruff action supports a healthier scalp environment.
Mentioned only
Oligopeptide-29 0.8% is disclosed. Other key actives (Salicylic Acid, Piroctone Olamine, Climbazole, Hexamidine Diisethionate, Propanediol Caprylate, Capryloyl Glycine) are listed high in the INCI, before Phenoxyethanol, indicating concentrations likely above 1%.
Mentioned only
The INCI starts with Propylene Glycol, Glycerin, PEG-12 Dimethicone, indicating a lightweight, water-soluble base.
Mentioned only
The product contains multiple ingredients (Climbazole, Piroctone Olamine, Hexamidine Diisethionate, Oligopeptide-29, Propanediol Caprylate) specifically described as targeting dandruff-causing fungi.
Mentioned only
Capryloyl Glycine is listed in the INCI. Ingredient research supports its sebum-regulating properties.
Mentioned only
Salicylic Acid is listed in the INCI. Ingredient research supports its exfoliating properties.
Mentioned only
Oligopeptide-29 is listed in the INCI. Ingredient research supports its antimicrobial properties.
Mentioned only
“treats dandruff & itching”
The claim 'treats dandruff' uses therapeutic language for a medical condition. While the actives (Climbazole, Piroctone Olamine) are permitted in cosmetics, the strong claim of 'treats' could be seen as crossing into drug territory under the Drugs & Cosmetics Act 1940 if not appropriately licensed.
“45% reduction in Dandruff in 4 weeks”
This quantified claim lacks publicly available details of the consumer study (sample size, methodology, full report) to verify its basis, which is required for specific percentage claims under ASCI guidelines.
“38% reduction in Scalp irritation in 4 weeks”
This quantified claim lacks publicly available details of the consumer study (sample size, methodology, full report) to verify its basis, which is required for specific percentage claims under ASCI guidelines.
